DE | EN
Merz Annual Report:
Merz is an independent, internationally active pharmaceutical company with a focus on aesthetics and neurotoxins. Its own research and development as well as a customized and innovative product portfolio make Merz one of the most important companies in aesthetic medicine. In addition, Merz develops and produces products and therapies for neurology and medical dermatology. In this annual report, Heisters & Partner, together with Merz’s communications experts, looks into the future of the company. The complex-free active ingredient botulinum neurotoxin, developed by Merz, plays an important role here and its properties are explained in detail. Under the motto »Shaping the future,« the report sheds light on the emerging business area of aesthetic medicine, explains how the new active ingredients and medications work, and highlights the leaps in innovation and the future potential of the pharmaceutical company. Clear and authentic imagery and the light, uncluttered layout effectively support the storyline and describe how the research of the pharmaceutical company Merz is becoming a driving force for forward-looking approaches.
Annual Report
The annual report uses report-like stories to give readers an insight into the neurology and aesthetics specialist's substantial future viability and makes it tangible through vivid examples. We were particularly interested in the narrative thread, which, in the mixture of information and reports, brings the complex relationships into a clearly understandable framework and conveys the company's strategy to the reader in an impressive and credible way.
Image Spread
Top